COMMUNIQUÉS West-GlobeNewswire

Liminatus Pharma Engages Synex as Contract Research Organization to Support Phase 1/2a Clinical Development of CD19xCD22 bivalent CAR-T therapy
24/08/2026
Engagement advances clinical execution of IBC101, Liminatus’ CD19xCD22 bivalent CAR-T therapy for relapsed or refractory B-cell malignancies FULLERTON, Calif., Aug. 24, 2026 (GLOBE NEWSWIRE) -- Liminatus Pharma, Inc. ( [...]
Bionano to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
24/08/2026
SAN DIEGO, Aug. 24, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that management will present and host 1x1 meetings at the H.C. Wainwright 28th Annual Global Investment Conference on [...]
ADARx Pharmaceuticals Receives FDA Fast Track Designation for Onvuzosiran for the Treatment of HAE
24/08/2026
SAN DIEGO, Aug. 24, 2026 (GLOBE NEWSWIRE) -- ADARx Pharmaceuticals, Inc. (ADARx), a late-stage clinical biotechnology company developing next-generation siRNA therapeutics, announced today that it has received Fast [...]
AEON Biopharma Designates Former FDA Neuroscience Leader Paul Lee, M.D., Ph.D. as Acting Chief Regulatory Officer
24/08/2026
- Former Deputy Director of the FDA’s Office of Neuroscience - Dr. Lee has previously advised AEON through Clintrex Research LLC (Clintrex), an affiliate of BlueRidge Life Sciences, on the regulatory strategy for ABP- [...]
Erasca Granted FDA Fast Track Designation for Pan-RAS Molecular Glue ERAS-0015 in Patients with Metastatic Pancreatic Adenocarcinoma
24/08/2026
Designation follows encouraging Phase 1 activity across multiple tumor types including 2L+ KRAS G12X pancreatic cancer Three potentially registration-enabling trials planned across pancreatic and lung cancers Additional [...]
Arbutus Commences US$230 Million Modified “Dutch Auction” Tender Offer of its Common Shares at a Price Not Greater Than US$5.75 Nor Less Than US$5.00 Per Share
24/08/2026
WARMINSTER, Pa., Aug. 24, 2026 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company focused on infectious disease, today announced the [...]
BriaCell Advances Personalized Melanoma Immunotherapy Vaccine Candidate, Bria-MEL+™
24/08/2026
Cell-based immunotherapy program is designed to harness patients’ own immune systems Bria-MEL+ is a personalized, off-the-shelf immunotherapy vaccine candidate intended to enable patient specific treatment without [...]
BridgeBio to Present New Acoramidis Data from Open-Label Extension Analyses in ATTR-CM at ESC Congress 2026
24/08/2026
PALO ALTO, Calif., Aug. 24, 2026 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a biopharmaceutical company focused on developing medicines for genetic conditions, announced [...]
La Commission européenne autorise TECVAYLI®▼ (teclistamab) de Johnson & Johnson associé au daratumumab dans le traitement du myélome multiple récidivant ou réfractaire, offrant ainsi une nouvelle référence thérapeutique potentielle
24/08/2026
Cette autorisation repose sur des données de Phase 3 sans précédent, démontrant une amélioration statistiquement significative de la survie sans progression et de la survie globale par rapport aux schémas thérapeutiques [...]
Kraig Biocraft Laboratories Boosts Spider Silk Output More Than 30% During the Most Technically Challenging Season of the Year
24/08/2026
Company Achieves Record Growth Through Peak Rainy Season, with Management Confirming Even Greater Output Within Reach ANN ARBOR, Mich., Aug. 24, 2026 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB [...]
ANI Pharmaceuticals Appoints Henry Gosebruch to Board of Directors
24/08/2026
– Appointment strengthens board as ANI accelerates transformation into a leading Rare Disease Company – PRINCETON, N.J., Aug. 24, 2026 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) [...]
WONDERLAB and United Family Healthcare | Global Health Summit 2026
24/08/2026
HONG KONG, Aug. 24, 2026 (GLOBE NEWSWIRE) -- The partnership will advance microbiome research in metabolic health, while WONDERLAB showcases SHAPE100™ research and its AKKKING™ metabolic-health formula. WONDERLAB has [...]
A Race Against Blindness Launches New Yukon Denali + Serenova Trailer Fundraiser to Help Cure Childhood Blindness
24/08/2026
One of the nonprofit’s most-loved campaigns returns with an upgraded 2026 GMC Yukon Denali, Grand Design Serenova travel trailer, and $50,000 cash—all supporting research for inherited retinal diseases GILBERT, Ariz. , [...]
NRG Therapeutics Presents Data on Lead Clinical Asset NRG5051 Confirming Novel Disease-Modifying Approach to ALS
24/08/2026
Poster presentation at the ALS Association’s ALS Nexus conference, August 23-26 Disclosed that NRG5051 acts by inhibiting the mPTP through a novel NLRX1-mediated mechanism of action Data showed that NRG5051 displays [...]
First Patient Treated in PIONEER-1 Registrational Trial of Privosegtor for Optic Neuritis
24/08/2026
The PIONEER program marks a key step toward potential first-in-class neuroprotection for optic neuritis and other neurological diseases, supported by positive Acuity Phase 2 data, FDA Breakthrough Therapy and EMA PRIME [...]
First Patient Treated in PIONEER-1 Registrational Trial of Privosegtor for Optic Neuritis
24/08/2026
The PIONEER program marks a key step toward potential first-in-class neuroprotection for optic neuritis and other neurological diseases, supported by positive Acuity Phase 2 data, FDA Breakthrough Therapy and EMA PRIME [...]
TME Pharma provides update on its activities
24/08/2026
TME Pharma provides update on its activities TME Pharma enters the final evaluation phase of advanced discussions with two potential partners for a license agreement. Discussions and potential partnership are aimed at [...]
TME Pharma fait le point sur ses activités
24/08/2026
TME Pharma fait le point sur ses activités TME Pharma entre dans la phase finale d’évaluation de négociations avancées avec deux partenaires potentiels en vue d’un accord de licence. Ces négociations et ce partenariat [...]
New EON hearing aid portfolio strengthens Phonak’s leadership in speech understanding, scene intelligence and Made-For-All connectivity
24/08/2026
STÄFA, Switzerland, Aug. 24, 2026 (GLOBE NEWSWIRE) -- Phonak today launched EON, its next-generation hearing aid platform. Powered by the newly developed HYPERSONIC™ chip, EON combines Spheric Speech Clarity 3.0, [...]

Pages